In This Article:
As global markets react to the recent U.S. election results, with major indices like the S&P 500 and Nasdaq Composite reaching record highs, investors are closely watching how anticipated policy changes might impact economic growth and inflation. In this environment of optimism tempered by uncertainty, companies exhibiting strong revenue growth coupled with high insider ownership can offer unique insights into potential investment opportunities.
Top 10 Growth Companies With High Insider Ownership
Name | Insider Ownership | Earnings Growth |
People & Technology (KOSDAQ:A137400) | 16.4% | 36.6% |
Archean Chemical Industries (NSEI:ACI) | 22.9% | 42.1% |
Kirloskar Pneumatic (BSE:505283) | 30.3% | 26.3% |
Laopu Gold (SEHK:6181) | 36.4% | 33.9% |
Medley (TSE:4480) | 34% | 30.4% |
Seojin SystemLtd (KOSDAQ:A178320) | 31.1% | 49.1% |
Findi (ASX:FND) | 34.8% | 64.8% |
Plenti Group (ASX:PLT) | 12.8% | 107.6% |
Brightstar Resources (ASX:BTR) | 16.2% | 84.6% |
UTI (KOSDAQ:A179900) | 33.1% | 134.6% |
Let's take a closer look at a couple of our picks from the screened companies.
ABL Bio
Simply Wall St Growth Rating: ★★★★★☆
Overview: ABL Bio Inc., a biotech research company, develops therapeutic drugs for immuno-oncology and neurodegenerative diseases and has a market cap of ₩1.84 trillion.
Operations: The company's revenue is primarily derived from its biotechnology segment, specifically startups, amounting to ₩32.95 billion.
Insider Ownership: 30.5%
Revenue Growth Forecast: 24.7% p.a.
ABL Bio is set to become profitable within three years, with earnings projected to grow 48.15% annually and revenue expected to increase by 24.7% per year, surpassing the Korean market average of 10.1%. Despite high share price volatility recently, no substantial insider trading activity has been reported over the past three months. The company's Return on Equity is forecasted at a modest 13%, indicating room for improvement in profitability metrics.
P/F Bakkafrost
Simply Wall St Growth Rating: ★★★★☆☆
Overview: P/F Bakkafrost, along with its subsidiaries, is engaged in the production and sale of salmon products across North America, Western Europe, Eastern Europe, Asia, and other international markets with a market cap of NOK38.72 billion.
Operations: The company's revenue segments include Sales and Other at DKK10.27 billion, Farming Faroe Islands at DKK3.92 billion, Fishmeal, Oil and Feed at DKK3.13 billion, Farming Scotland at DKK1.68 billion, Services at DKK899.29 million, Freshwater Faroe Islands at DKK686.59 million, and Freshwater Scotland at DKK119.99 million.